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Summary Overwhelming post-splenectomy infection (OPSI) remains a long-term
risk in asplenic patients, which may be reduced by appropriate preventive measures.
Speciﬁc guidelines have been developed to lower its incidence.
Aims: To assess the implementation of guidelines by specialized physicians of aImmunization university hospital and primary care physicians.
Methods: A retrospective review of splenectomized patients’ medical ﬁles over a
six year period was carried out. Patients’ general practitioners were contacted and
a questionnaire was sent to them.
Results: 154 individuals who underwent splenectomy between 2000 and 2005
were eligible (62 children and 92 adults): 70.8% received vaccine, 44% received
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pneumococcal vaccine against Haemophilus inﬂuenzae type b with a good cover of
children population (88.7%), 24% received meningococcal vaccine. Prophylactic antibi-
otics were prescribed in 74% of patients. Septic events were found in 8.4%, and global
mortality was 11.7% during a mean follow-up period of 4.5 years.
Conclusions: Management of the infectious risk in asplenic patient has to be improved:
some of the patients are not correctly identiﬁed as at risk of OPSI, and vaccination
against Neisseria meningitidis is insufﬁcient. Hospital specialists should improve the
implementation of guidelines and give better information to general practitioners
involved.
dulaziz University for Health Sciences. Published by Elsevier
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pidou). These three hospitals, with a total of
2600 beds, cover various specialities: paediatric© 2011 King Saud Bin Ab
Ltd. All rights reserved.
Introduction
Individuals with anatomical or functional asple-
nia are known to be at increased risk of severe
and potentially life-threatening infections [1]. Fur-
thermore, multiple reviews have documented that
despite the implementation of education, prescrip-
tion of prophylactic antibiotics and vaccination
against encapsulated bacteria are far from sys-
tematic [2]. It has been estimated that there are
500,000 asplenic patients in France [3] of whom 50%
are splenectomized, while the remaining patients
have functional hyposplenism (mostly severe liver
disease, celiac sprue, but also sickle-cell disease,
thalassemia, autoimmune or granulomatous dis-
eases).
These patients have a considerable risk of
developing invasive infections, such as meningitis
or bacteremia. These infections are called over-
whelming post splenectomy infections (OPSI) and
were identiﬁed in 1952 [4]. Their major char-
acteristics are a high mortality rate (up to 70%
within 48 h in a review of the literature on post-
splenectomy sepsis from 1952 to 1987 [5]), a
minor and short prodromic phase, and a high
bacteremia or parasitemia. Pathogens most often
involved are encapsulated bacteria such as Strep-
tococcus pneumoniae, Haemophilus inﬂuenzae,
Neisseria meningitidis or intra-erythrocytic para-
sites or bacteria where elimination is mostly splenic
(Babesia spp., Ehrlichia spp., Plasmodium spp.)
[6]. S. pneumoniae is the ﬁrst agent involved in
OPSI, followed by H. inﬂuenzae type b in children
[7].
The risk for asplenic patients to develop an
OPSI is estimated to be 0.89% per person per year
[8].
Several recommendations and guidelines exist
in the literature, the most recent being published
h
g
o
an 2010 in Australia [9], the United States in
006, and Great Britain in 2008 [10—13]. These
ecommendations are based on three principles:
mmunization against S. pneumoniae, N. meningi-
idis, H. inﬂuenzae type b, and inﬂuenza, lifelong
ntibiotic prophylaxis, and education with written
nformation and cards to alert health profession-
ls, and risks associated with travels or animal
ites. Despite these recommendations and efforts
o implement them, the incidence of OPSI remains
onstant over time, ranging from 4.25% in 1973 [14]
o 3.2% in 2001 [15].
The mortality of OPSI and the high number of
ases of OPSI in young patients without comor-
idity brings into question the compliance and
fﬁcacy of these preventive measures. Because
he adherence to preventive measures is critical
o their success and is reported to be low while
he mortality of OPSI remains high, a retrospec-
ive study was conducted to assess the vaccination
tatus and antibiotic prophylaxis in splenectomized
dults and children during a 6-year period in
he Paris Descartes University hospitals. It was
lso investigated whether the general practition-
rs in charge of the patients were up-to-date with
ecommendations.
ethods
retrospective study was carried out in the
aris Descartes University hospitals. Three major
ospitals were included (Necker, Cochin and Pom-aematology and immunology, adult and paediatric
eneral surgery, adult haematology, gastroenterol-
gy, gynaecology, infectious and tropical diseases
nd internal medicine.
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Table 1 Demographic data, underlying diseases and outcome of 154 splenectomized patients.
All patients Adults Children
Number of patients 154 92 (60) 62 (40)
Age at splenectomy (years) 36.8± 27.6 56.2± 17.8 8± 5.0
Indication of splenectomy
Haemolytic anemiaa 33 (21) 9 (10) 24 (39)
Idiopathic thrombocytopenia 32 (20) 17 (18) 15 (24)
Trauma/iatrogenic 26 (17) 25 (27) 1 (2)
Hematological malignancy 26 (17) 22 (24) 4 (6)
Hemoglobinopathy (sickle cell disease and thalassemia) 10 (6) 1 (1) 9 (15)
Others 31 (20) 22 (24) 9 (15)
Comorbidities
Evolutive neoplasia 38 (25) 36 (39) 2 (3)
Immunosuppressive treatmentb 24 (16) 11 (12) 13 (21)
Immune deﬁciencyc 7 (5) 1 (1) 6 (10)
Diabetes mellitus 4 (3) 4 (4) 0 (0)
HIV infection 2 (1) 1 (1) 1 (2)
Invasive infections 13 (8.4) 9 (10) 4 (6)
Global mortality 18 (12) 15 (16) 3 (5)
Data is expressed as mean± standard deviation or number (percentage).
a Excepting hemoglobinopathy.
b Immunosuppressive treatment consisted in: steroid therapy, antineoplasic treatment (chloraminophene, ﬂudarabine, ritux-
imab, cyclophosphamide, cladribine, cytarabine), inﬂiximab treatment, anti rejection treatment (mycophenolate, ciclosporin).
c Immune deﬁciency consisted in: Fas-ligand deﬁciency, Wiskott Aldrich syndrome, severe combined immune deﬁciency, Canale-
Smith syndrome, Evans syndrome, bone marrow transplantation, liver cirrhosis.
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ePatients who underwent splenectomy from 1
anuary 2000 to 31 December 2005 were identiﬁed
sing the database of pathology departments in the
hree participating hospitals. Criteria of exclusion
ere the unavailability of medical charts and death
uring or within the ﬁrst 48 h following splenec-
omy.
Data were ﬁrst collected from these different
edical units and demographic and clinical data
ere reviewed extensively: they included the age,
he indication of splenectomy, co-morbidities, vac-
ination status and timing, antibiotic prophylaxis,
ntibiotics used at home in case of fever, and
nformation which had been given to patients or
elatives. All infectious events requiring hospital-
zation and their characteristics were also studied
uring a follow-up of at least two years after
plenectomy.
Last, the patients’ general practitioners (GP)
ere questioned. They were contacted by tele-
hone and sent a standardized questionnaire
ncluding details of antibiotic prescription, immu-
ization against S. pneumoniae, H. inﬂuenzae type
, N. meningitidis, inﬂuenza virus and information
elivered to the patients. 77 GPs were contacted,
f whom 46 were still following patients selected in
he study and answered the questionnaire.
a
m
i
aAn univariate analysis was used to assess predic-
ive factors of failure for preventing OPSI. Statistics
ests used were Chi2 Pearson test and Fischer’s
est. Statistical analyses were performed using SPSS
oftware version 12 (SPSS Inc., Chicago, Ill). All
tatistical analyses were performed using 2-tailed
ests, with signiﬁcance at p < 0.05.
esults
eneral characteristics
95 patients underwent splenectomy during the
tudy period. 34 medical charts were lost, and
deaths occurred during surgery or within the
rst 48 h. A total of 154 charts were thus
eviewed. Demographic characteristics, comorbidi-
ies, and indications for splenectomy are presented
n Table 1. Indications for splenectomy mainly
onsisted in haemolytic anemia in children (39%
ersus 10% in adults, p < 0.0001). Underlying dis-
ases were mainly hereditary spherocytosis and
utoimmune haemolytic anemia. Hematological
alignancies and solid tumors were the lead-
ng indications for splenectomy in adults (38% in
dults versus 7% in children, p = 0.0034) (Fig. 1).
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Figure 1 Age repartition for indications of splenectomy.
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Global mortality during follow-up was 11.7%
(18 patients).
Adherence to preventive measures in
hospital (Table 2)
S. pneumoniae
75 pneumococcal vaccinations were performed
before surgery over 128 programmed procedures
(vaccine before surgery of 58.6%). 34 vaccinations
were administrated after surgery.
H. inﬂuenzae type b
All children born after 1992 (n = 38) received vacci-
nation, as recommended since 1992 in France. 29
other patients (15/92 adults and 14/62 children)
were immunized before surgery and 22 after (20/92
adults and 2/62 children).
N. meningitidis
31 meningococcal vaccinations were administered
before surgery (5/92 adults: 19-, 19-, 23-, 36-, and
67-year old and 26/62 children) and 6 after sur-
Table 2 Immunizations coverage and antibiotic pro-
phylaxis among children and adults populations at
hospital discharge.
Children = 62 Adults = 92
Streptococcus
pneumoniae
65% 75%
Haemophilus
inﬂuenzae type b
89% 37%
Neisseria meningitidis 45% 10%
All the 3 recommended
vaccines
40% 4%
No immunization 23% 35%
Antibioprophylaxis 90% 64%
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ical intervention (2 adults and 4 children). Many
erotypes were used: A, A-C, A-C-Y-W135.
Vaccination against inﬂuenza virus was reported
n only two medical charts, corresponding to a cover
f 1.3%.
ll vaccinations or none
9 patients received all recommended immuniza-
ions (18.8%). Among these patients, half of them
ere splenectomized for haemolytic anemia (49%)
nd a fourth for idiopathic thrombocytopenia (24%),
s presented in Fig. 3. 46 patients (29.9%) did not
eceive any vaccination after hospital discharge;
ndications of their splenectomy are presented in
ig. 4 (mostly represented by splenectomy for solid
umor and for trauma).
ntibiotic prophylaxis
07 patients received oral penicillin, 7 patients
eceived another antibiotic: amoxicillin (3), rox-
thromycin (1), benzathine benzylpenicillin (1),
orﬂoxacin (1), and spiramycin (1). A total of 74.0%
f the population received an antibioprophylaxis:
0% of children and 64% adults. The duration of
ntibioprophylaxis was not reported, but when it
ad been prescribed, no GP had stopped it.
eneral practitioner’s attitudes
mong 46 patients still followed by a GP, 8 outpa-
ients were never immunized against pneumococcal
nfection: the pneumococcal vaccine by general
ractitioner (GP) was 82.6%. Only 2 of these 46
atients did not receive any antibioprophylaxis.
20 patients were vaccinated against inﬂuenza
irus at least once during the follow-up period (of
3.5%).
Factors linked to pneumococcal vaccination
y GP were analysed. They are presented in
able 3. There was a good knowledge of infec-
ious risk in patients under immunosuppressive
herapy and patients splenectomized for idiopathic
hrombocytopenia. This contrasted with patients
plenectomized for trauma or hemoglobinopathy
hich were not identiﬁed as at risk.
Finally, the differences between the practices
f the GP and hospital physicians are presented in
able 4: pneumococcal vaccine was equivalent in
he two groups and so was antibioprophylaxis, but
nformation given to patients differed, with 19.5%
f patients informed at hospital and 62.5% by their
P.
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rigure 2 Indication for splenectomy among 13 patients
ho presented a subsequent infection.
escription of infections requiring a
ospitalization
3 patients (8.4%) including 6% of children and 10%
f adults, after a mean interval of 16 months follow-
ng splenectomy, developed an infection requiring
ospitalization, with a mortality rate in this group
f 23.1%. Inversely, mortality due to infections
n this study is 4 deaths among 18, correspond-
ng to 22.2%. The clinical characteristics of these
nfections consisted of six episodes of pneumo-
ia, ﬁve bacteremia, and two pyelonephritis. The
dentiﬁed pathogens (9 out of 13 events) were:
scherichia coli in three cases, Klebsiella pneu-
oniae, Klebsiella oxytoca, one pneumonia for
hich several pathogens were isolated including
treptococcus mitis, Neisseria sicca, and Staphy-
ococcus aureus, one Pneumocystis jiroveci, one
tenotrophomonas maltophilia, and one acute
pisode of malaria due to Plasmodium falciparum.
hese 13 patients had a pneumococcal-vaccination
over of 92.3%, haemophilus-vaccination cover of
2.3%, meningococcal-vaccination cover of 15.4%,
nd they received antibiotic prophylaxis in 69.3% of
ases. Indications of splenectomy among patients
ho presented an OPSI are presented in Fig. 2.
iscussionhe aim of the study was to determine how hos-
ital physicians and general practitioners followed
49%
24%
0%
7%
3%
7%
Haemolyc anemia (14)
Idiopathic thrombocytopenia (7)
Hemoglobinopathy (3)
Trauma (2)
Hematological malignancy (1)
Other (2)
igure 3 Indications for splenectomy in fully immunized
atients (i.e. having received the 3 recommended vac-
ines before surgery).
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oigure 4 Indications for splenectomy among non-
accinated patients.
uidelines for prevention of infections in splenec-
omized patients in Paris.
Concerning immunizations, we observed good
accine coverage against pneumococcal infection
70.8%), was observed especially for patients who
ere followed by a GP (82.6%). This rate is in the
pper range of that previously reported, which var-
ed from 32% to 75% [16—18]. However, the need for
mmunization against H. inﬂuenzae type b and N.
eningitidis is not well taken into account by hos-
ital physicians, with respectively 44% and 24% of
accine coverage at hospital discharge. The insufﬁ-
ient coverage for meningococcal and Haemophilus
accinations was found in all recent studies, with
imilar results in a 2001 study in Canada [19,20,21].
Antibiotic prophylaxis was prescribed to 74%
f patients in hospital. However, patients with
ower coverage were those who underwent par-
ial splenectomy and splenectomy for solid tumor.
ndeed, it is now well known that an infectious risk
xists even in patients with a residual spleen—–the
mmune capacity of residual or accessory spleen
eing not assessable [3,22]. The lack of proper
ntibiotic prophylaxis in patients with solid tumor
an be explained by the fact the infectious risk
ssociated with splenectomy might be perceived as
inor when compared with the risk associated with
alignancies. In this clinical setting, it is, however,
ecommended to insist on the use of antibiotics at
ome in case of fever and on antimicrobial pro-
hylaxis during the period of immunodeﬁciency.
ndeed, those patients are at particularly high risk
f infections, since they can also be neutropenic or
eceive high doses of corticosteroids.
Data regarding advice given to patients and pre-
cription of antibiotics in case of fever occurring
t home were difﬁcult to collect in this series.
his information is often not reported in clinical
harts. Percentage of patients for whom antibi-
tics were prescribed in case of fever by hospital
hysicians and GP were respectively 13% and 8.7%.
any studies tried to evaluate patients’ knowledge
egarding their infectious risk. In order to assess the
bservance of these prophylaxes, a recent study
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Table 3 Vaccination against Streptococcus pneumoniae by GPs (after splenectomy).
All patients = 46 Vaccinated = 29 (63) Non vaccinated = 17 (37) p-Value
Age (years) 37.5± 28.7 38± 26 NS
Gender 17 men/12 women 8 men/9 women NS
Hematological malignancies 7 (24) 3 (18) NS
Hemoglobinopathy 0 3 (18) <0.005
Haemolytic anemia 13 (45) 2 (12) NS
Trauma 0 3 (18) <0.0005
Idiopathic thrombocytopenia 6 (21) 0 <0.006
Diabetes 1 (4) 1 (6) NS
Immunosuppressive treatment 7 (24) 0 <0.002
HIV 1 (4) 1 (6) NS
Cancer 6 (21) 5 (29) NS
Immune deﬁciency 1 (4) 0 NS
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tData is expressed as mean± standard deviation or number (pe
NS: no statistically signiﬁcant difference observed.
evaluated the presence of penicillin in urine of
recently splenectomized patients, who were known
to have been prescribed oral penicillin: only 42%
took it correctly [23]. Similarly, a questionnaire-
based study performed months to years after
splenectomy, assessed the ‘‘level of knowledge
about infectious risk’’ and ‘‘good behaviour in case
of fever’’: all patients were interviewed by a doc-
tor or a nurse before discharge and received a
card or bracelet and underwent the 3 classical
vaccinations. Nevertheless, only 47% of patients
recalled having received good information, and 27%
reported a correct behaviour in case of fever [24].
Furthermore, results about missing pneumo-
coccal vaccination by GP could help identifying
a high-risk population. It appears that patients
splenectomized for hemoglobinopathy (thalassemia
and sickle-cell disease) and trauma are indeed
under-vaccinated. However, an increase of infec-
tion rate in this group was not observed, owing
to a potential residual splenic tissue in this con-
text, as well as the small sample size of our
population. Conversely, patients splenectomized
for idiopathic thrombocytopenia or patients taking
immunosuppressive treatment were those com-
pletely vaccinated.
p
p
S
Table 4 Anti infectious prophylaxis rate obtained in hospit
Hospital: 15
Pneumococcal immunization 109 (70.8)
Meningococcal immunization 37 (24)
Haemophilus immunization 51 (44)
Antibioprophylaxis 114 (74)
Antibiotic in case of fever 20 (13)
Information about infections 30 (19.5)
GP: general practitioner.age).
The prevention and infection rates in immuno-
ompromised children and young adult patients
as also speciﬁcally studied. A good adherence to
uidelines in this group was observed, especially
n children splenectomized for haemolytic anemia
xcepting hemoglobinopathy (paediatric haematol-
gy ward).
In the same way, comparing practices in adults
nd children populations, it was noticed that 65%
f children and 75% of adults were vaccinated
gainst S. pneumoniae, 89% of children and 37%
f adults against H. inﬂuenzae B, 45% of children
nd 10% of adults against Neissseria meningitidis.
0% of children and 4% of adults only had all vac-
inations, 23% of children and 35% of adults had
one. Concerning antibioprophylaxis, 90% of chil-
ren and 64% of adults received a prescription. 6%
f children presented an OPSI, compared to 10% of
dults.
Several observations may explain these ﬁnd-
ngs. These children were followed by specialized
hysicians well aware of the risk of OPSI. Further,
hese children were receiving long-term antibio-
rophylaxis (mostly cotrimoxazole) which may also
rotect against some encapsulated bacteria such as
. pneumoniae.
als and prescribed by primary care practitioners.
4 (percentage) GP: 46 (percentage)
38 (82.6)
No data
No data
4 (66.7)
4 (8.7)
30 (65.2)
C ion
t
t
I
o
i
r
r
r
a
c
p
Y
t
a
a
r
t
w
f
i
p
g
h
c
p
i
l
s
o
p
r
b
a
5
b
t
I
t
t
a
f
e
d
C
I
a
t
c
G
o
t
b
r
s
t
h
A
W
P
V
s
R
[
[
[linical practice study evaluating infection prevent
One of the speciﬁcities of this study was
o include children from a large European cen-
re for treatment of primary immunodeﬁciencies.
mmunocompromised patients represent 65.6% of
ur population, which is higher than in other stud-
es, this bias could explain the higher mortality
ate (11.7%) compared to other studies. Applying
ules of prevention for those susceptible patients
emains important. However, few data are available
bout the efﬁcacy of the vaccination in immuno-
ompromised hosts, and the guidelines for OPSI
revention in this group of patients remain elusive.
et, in immunocompromised patients, the applica-
ion of guidelines and the use of vaccination and
ntibioprophylaxis is able to avoid some infection
nd especially infection with encapsulated bacte-
ia. This work highlights the fact that departments
hat were involved in managing this kind of patients
ere more effective in applying recommendations.
The small size of this population did not permit
or the study of the characteristics of OPSI: only 13
nfectious events were recorded, in particular no
neumococcal infection (explained partially by the
ood rate of vaccine).
Taking these observations into consideration,
ow can patient care be improved? Written proto-
ols should be used by all teams managing asplenic
atients. A letter can be given to patients with
nformation about immunization, antibiotic prophy-
axis, and recommendations in case of fever. It also
eems important for the medical unit in charge
f splenectomized patients to contact the general
ractitioner for information about the infectious
isks associated with asplenism. Prevention has to
e stressed to the patient (life-long infectious risk)
nd pneumococcal vaccination done at least every
years with new vaccine trials to be generated to
etter induce immunological protection.
Some authors recommended spleen registry [9],
o improve adherence to recommended guidelines.
n Melbourne, the Victorian Spleen Registry regis-
ers splenectomized patients since 2003, and sends
hem recommendations and educational resources,
nd annual reminders about vaccinations. Data
rom this registry in 2007 showed a 59% adher-
nce to antibiotics, which is better than published
ata.
onclusionn this study, 8.4% of the population presented
n infectious event requiring hospitalization. On
he other hand, GPs’ knowledge about pneumo-
occal appeared to be good, and the role of the
[
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P is critical GP in education and prevention
f infectious risk in splenectomized patients,
hroughout their lives. Speciﬁc attention should
e paid to immunocompromised patients, who
equire stringent immunizations and education, and
pecial vigilance is required for patients splenec-
omized for trauma or solid tumor (adults) and for
emoglobinopathy (children).
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